Detail Article

Informations générales (source: ClinicalTrials.gov)

Numéro NCT

NCT04361604 En recrutement IDF

Titre

Clinical Characterisation Protocol for COVID-19 in People Living With HIV (COVIDHIV)

Type

Observational

Pathologie

Phase

Promoteur

Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)

Date de début

avril 2020

Date de fin

octobre 2020

Dernière mise à jour

28 décembre 2024

Résumé

There is very little data so far to determine whether people living with HIV (PLWHIV) are at greater risk of COVID-19 acquisition or severe disease. HIV infection is associated with deficiencies in both humoral and cell-mediated immunity that could potentially alter the course and severity of common infections. The investigators will study the correlation between clinical and immunovirological data. The singularity of this work is to have an in-depth immunovirological approach linked to the clinical characteristics in COVID-19 HIV co-infected patients. COVIDHIV is the only study to date to offer this combined approach in PLWHIV. This protocol is a historical and prospective cohort study of PLWHIV presenting COVID-19 The primary objectives are to describe the course of COVID-19 disease in patients infected with HIV

Détail

Voir le détail Infectious diseases are a major cause of death worldwide. Recently a new coronavirus named SARS-CoV-2 has been identified as responsible of an initial epidemic respiratory disease, named COVID-19, in China since the 31 December 20191. COVID-19 has developed into a pandemic, with small chains of transmission in many countries and large chains resulting in extensive spread in a some countries, such as Italy, Iran, South Korea, and Japan 2 . Most countries are likely to have spread of COVID-19, at least in the early stages, before any mitigation measures have an impact and the COVID -19 epidemic is gradually taking hold in France 3. There is very little data so far to determine whether people living with HIV (PLWHIV) are at greater risk of COVID-19 acquisition or severe disease. HIV infection is associated with deficiencies in both humoral and cell-mediated immunity that could potentially alter the course and severity of common infections. Although use of cART partially restores immune system, HIV-infected persons may remain at increased risk for morbidity associated with viral illnesses, especially if the ability to generate antigen-specific responses remains impaired 5. Additional factors, such as the high prevalence of smoking and chronic lung diseases among such patients, may further predispose HIV-infected patients to respiratory tract infections. Finally, they could be considered more vulnerable to SARS-CoV-2 infection because their immune systems are already under strain and cannot avoid the possibility of atypical presentations in these patients. Thus, we would like to implement a research as soon as possible concerning PLWHIV in order to adapt the care of these patients as fast as possible. The investigator will study the correlation between clinical and immunovirological data. The singularity of this work is to have an in-depth immunovirological approach linked to the clinical characteristics in COVID-19 HIV co-infected patients. COVIDHIV is the only study to date to offer this combined approach in PLWHIV. This protocol is a historical and prospective cohort study of PLWHIV presenting COVID-19 The primary objectives are to describe the course of COVID-19 disease in patients infected with HIV-1, and more specifically to: - Describe the clinical and the biological features of the COVID-19 disease in PLWHIV - Correlate the clinical characteristics with the immunovirological characteristics - Describe the major complications and determine the factors associated with a worse evolution in PLWHIV - Compare the data obtained to those of the similar works in progress in non PLWHIV - Evaluate post-infectious clinical effects at a distance from the acute phase This study will enroll 250 adult patients living with HIV (PLWHIV) with confirmed infection with SARS-CoV-2 since 1st January 2020. Recruitment of patients with Day 1 (enrolment) data is the priority. Twenty adult patients living with HIV (PLWHIV) without confirmed infection with SARS-CoV-2 will be enrolled only for qualitative interview. In order to be the most representative of PLHIV population and reach the number of patients to be included people who do not have social security affiliation or who are eligible may be included in the study. A derogation will be requested from the CPP for this. Research interventions include prospective collection of clinical data and biological sampling (blood, saliva, rectal swab (stool swab), urine, nasopharyngeal swab, conjonctival swab, semen (for 20 PLWHIV), CSF or other samples if indicated as part of standard care.). Auto-Questionnaires will be collected. Qualitative interviews will be realized in 40 patients (20 with COVID-19 and 20 without COVID-19) Fermer le détail

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
AP-HP - Hôpital Ambroise Paré	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Antoine Béclère	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Avicenne	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Bicêtre	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Europeen Georges Pompidou	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Henri Mondor-Albert Chenevier	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Hôtel-Dieu	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital La Pitié-Salpêtrière	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Lariboisiere-Fernand Widal	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Louis Mourier	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Necker-Enfants Malades	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Raymond Poincaré	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Saint Antoine	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
AP-HP - Hôpital Tenon	CHERET Antoine	Active, sans recrutement	02/12/2024 12:47:14	Contacter
CHI DE CRETEIL	Evguenia KRASTINOVA	En recrutement IDF	10/05/2024 11:36:59	Contacter
HOPITAL FOCH	DAVID ZUCMAN	En recrutement IDF	23/12/2024 08:04:24	Contacter
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Department of Internal Medicine and Clinical Immunology of Professor Cécile Goujard - Le Kremlin-Bicêtre - France	Antoine Chéret, Dr			Contact (sur clinicalTrials)

Critères

Genre

Tous

Nombre d'inclusion

Critère d'inclusion

Inclusion Criteria:

Inclusion criteria for the 250 patients with COVID19

- Patient living with HIV (PLWHIV)

- Patient with confirmed infection with SARS-CoV-2 since 1st January 2020 with and
without criteria of hospitalisation.

Inclusion criteria for the 20 patients without COVID19 (who will only realize the
qualitative interview)

- Patient living with HIV (PLWHIV)

- Patient who did not have COVID-19

Critère de non inclusion

Exclusion criteria for the 250 patients with COVID19

- Confirmed diagnosis of another pathogen than SARS-CoV-2

- Refusal by participant, or appropriate representative.

- Being under guardianship or trusteeship mandate for future protection

- Participate to another study without consent of the promoter

- Patients less than 18 years old

- No Beneficiary or entitled to a social security scheme or state medical aid.

Exclusion criteria for the 20 patients without COVID19 (who will only realize the
qualitative interview)

- Refusal by participant, or appropriate representative.

- Being under guardianship or trusteeship mandate for future protection

- Participate to another study without consent of the promoter

- Patients less than 18 years old

- No Beneficiary or entitled to a social security scheme or state medical aid.

NCT04361604 - Clinical Characterisation Protocol for COVID-19 in People Living With HIV (COVIDHIV)

Informations générales
Etablissements
Critères
Accès à la fiche NCT

Retour en haut